BRCA1 expression is required for efficacy of vinorelbine and is a predictive biomarker in malignant mesothelioma

被引：0
|
作者：
Busacca, S. [1 ]
Sheaff, M. [1 ]
Gray, S. G. [1 ]
O'Byrne, K. J. [1 ]
Kerr, K. [1 ]
Schmitt-Opitz, I. [1 ]
Soltermann, A. [1 ]
Pass, H. [1 ]
Quinn, J. E. [1 ]
Fennell, D. A. [1 ]
机构：
[1] Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72632-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine
    Panagopoulou, Maria
    Panou, Theodoros
    Gkountakos, Anastasios
    Tarapatzi, Gesthimani
    Karaglani, Makrina
    Tsamardinos, Ioannis
    Chatzaki, Ekaterini
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [22] Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant Mesothelioma
    Cao, Liang
    Yu, Yunkai
    Thomas, Anish
    Zhang, Jingli
    Onda, Masanori
    Meltzer, Paul
    Hassan, Raffit
    Pastan, Ira
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 16
  • [23] Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
    Hmeljak, Julija
    Erculj, Nina
    Dolzan, Vita
    Pizem, Joze
    Kern, Izidor
    Kovac, Viljem
    Cemazar, Maja
    Coer, Andrej
    VIRCHOWS ARCHIV, 2013, 462 (03) : 315 - 321
  • [24] Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
    Julija Hmeljak
    Nina Erčulj
    Vita Dolžan
    Jože Pižem
    Izidor Kern
    Viljem Kovač
    Maja Čemažar
    Andrej Cör
    Virchows Archiv, 2013, 462 : 315 - 321
  • [25] Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma
    Cao, Liang
    Yu, Yunkai
    Thomas, Anish.
    Zhang, Jingli
    Onda, Masanori
    Meltzer, Paul
    Hassan, Raffit
    Pastan, Ira
    CANCER RESEARCH, 2019, 79 (13)
  • [26] IS RRM1 A PREDICTIVE MARKER FOR VINORELBINE EFFICACY - THE RESULTS FROM A COHORT OF MALIGNANT PLEURAL MESOTHELIOMAS TREATED WITH CISPLATIN AND VINORELBINE
    Zimling, Zarah G.
    Santoni-Rugiu, Eric
    Bech, Cecilia
    Sorensen, Jens B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S790 - S791
  • [27] BRCA1 promoter hypermethylation and reduced BRCA1 protein expression in sporadic breast carcinomas
    不详
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 97 - 97
  • [28] BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
    Kan, Charlene
    Zhang, Junran
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 281 - 293
  • [29] BRCA1 Gene Mutation in Thymic Malignant Melanoma
    Yi, Eun Jue
    Park, Jong Ho
    Lee, Hae Won
    Cho, Soo Youn
    Na, Im Il
    Kang, Moon Chul
    ANNALS OF THORACIC SURGERY, 2013, 96 (02): : 677 - +
  • [30] Predictive BRCA1/2 testing of young women
    Adlard, Julian
    Rae, L.
    Hayward, J.
    Kraus, A.
    Sharif, S. Malik
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S47 - S47
12345